SaniHaiderKizilbashMDMPH

Oncology • Rochester, MN

Neuro-Oncology

Associate Professor, Division of Medical Oncology, Mayo Clinic

Join to view full profile

Dr. Kizilbash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kizilbash's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Emory UniversityMPH, Health Outcomes, 2008 - 2011
Beaumont Health (Royal Oak)Residency, Internal Medicine, 2005 - 2008
Aga Khan Medical CollegeClass of 2003

Certifications & Licensure

MN State Medical License 2011 - 2025
FL State Medical License 2016 - 2019
MI State Medical License 2005 - 2012
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Start of enrollment: 2011 Oct 01
Completed
Phase 1, Phase 2
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01
Active, not recruiting
Phase 3
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma Start of enrollment: 2019 May 01
Active, not recruiting
Phase 1
WSD0922-FU for the Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases Start of enrollment: 2019 Dec 20
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design.
Mahnoor Islam, Mason Webb, Ugur Sener, Sani H Kizilbash> ;Neuro-Oncology Advances. 2024 Mar 15
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
Sener, U., Webb, M., Breen, W., Neth, B., Laack, N., Routman, D., Brown, P., Mahajan, A., Frechette, K., Dudek, A., Markovic, S., Block, M., McWilliams, R., Dimou, A.,...> ;Journal of Immunotherapy and Precision Oncology. 2024 Feb 1
Methodological and analytical considerations for intra-operative microdialysis.
Cecile Riviere-Cazaux, Karishma Rajani, Masum Rahman, Juhee Oh, Desmond A Brown, Jaclyn F White, Benjamin T Himes, Ignacio Jusue-Torres, Moses Rodriguez, Arthur E Warr...> ;Fluids and Barriers of the CNS. 2023 Dec 19
1 citations
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
Cecile Riviere-Cazaux, Lucas P Carlstrom, Bryan J Neth, Ian E Olson, Karishma Rajani, Masum Rahman, Samar Ikram, Moustafa A Mansour, Bipasha Mukherjee, Arthur E Warrin...> ;NPJ Precision Oncology. 2023 Nov 29
1 citations
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
M J Webb, Bryan J Neth, Lauren M Webb, Jamie J Van Gompel, Michael J Link, Brian A Neff, Matthew L Carlson, Colin L Driscoll, Jim Dornhoffer, Michael W Ruff, Kelsey A ...> ;Neuro-Oncology Advances. 2023 Sep 22
Treatment outcome of metastasis to the pituitary gland: a case series of 21 patients with pathological diagnosis.
John L Atkinson, Dana Erickson, Sani H Kizilbash, Jason T Little, David M Routman, Jamie J Van Gompel, Sukwoo Hong> ;Neurosurgical Focus. 2023 Aug 1
2 citations
Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Bryan J Neth, Aditya Raghunathan, Sani H Kizilbash, Joon H Uhm, William G Breen, Derek R Johnson, David J Daniels, Ugur Sener, Ivan D Carabenciov, Jian L Campian, Soum...> ;Neurology. 2023 Sep 19
2 citations
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas.
Cecile Riviere-Cazaux, Lucas P Carlstrom, Karishma Rajani, Amanda Munoz-Casabella, Masum Rahman, Ali Gharibi-Loron, Desmond A Brown, Kai J Miller, Jaclyn J White, Benj...> ;Communications Biology. 2023 Jun 20
2 citations
Glioma Metabolic Feedback In Situ: A First-In-Human Pharmacodynamic Trial of Difluoromethylornithine + AMXT-1501 Through High-Molecular Weight Microdialysis.
Cecile Riviere-Cazaux, Bryan J Neth, Matthew D Hoplin, Bambi Wessel, Jason Miska, Sani H Kizilbash, Terry C Burns> ;Neurosurgery. 2023 Oct 1
1 citations
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Cecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, William J Laxen, Amanda Munoz-Casabella, Matthew D Hoplin, Samar Ikram, Abdullah Bin Zubair, Katherine M Anders...> ;Neuro-Oncology Advances. 2023 May 11
2 citations
Contemporary Treatment Outcome of Metastases to the Pituitary Gland.
Sukwoo Hong, John L Atkinson, Dana Erickson, Sani H Kizilbash, Jason T Little, David M Routman, Jamie J Van Gompel> ;World Neurosurgery. 2023 Apr 1
1 citations
Why has targeting EGFR aberrations in glioblastoma therapy had limited success?
Sani H Kizilbash> ;Expert Review of Anticancer Therapy. 2022 Dec 1
2 citations
Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
Mason Webb, Derek R Johnson, Anita Mahajan, Paul Brown, Bryan Neth, Sani H Kizilbash, Ugur Sener> ;Journal of Neuro-Oncology. 2022 Nov 1
7 citations
Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.
Shannon P Fortin Ensign, Robert B Jenkins, Caterina Giannini, Jann N Sarkaria, Evanthia Galanis, Sani H Kizilbash> ;Neuro-Oncology. 2023 Jan 5
2 citations
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.
Andres Ramos-Fresnedo, Ricardo A Domingo, Carlos Perez-Vega, Michael W Pullen, Oluwaseun O Akinduro, Joao P Almeida, Mark E Jentoft, Bernard R Bendok, Kaisorn L Chaich...> ;Journal of Neuro-Oncology. 2022 Jul 1
MET/HGF Coexpression as a Novel Predictive Biomarker for Response to MET Inhibitor Therapy in a Case of Psammomatous Melanotic Schwannoma.
Jenny J Li, Xiaoling Zhang, Neil Sankar, Lynn Espiritu, Sanjeev Redkar, Guo-Liang Yu, Sani H Kizilbash> ;JCO Precision Oncology. 2022 Jun 1
2 citations
Initial results of a phase II trial ofF-DOPA PET-guided re-irradiation for recurrent high-grade glioma.
William G Breen, Ryan S Youland, Sharmila Giri, Sawyer B Jacobson, Deanna H Pafundi, Paul D Brown, Christopher H Hunt, Anita Mahajan, Michael W Ruff, Sani H Kizilbash,...> ;Journal of Neuro-Oncology. 2022 Jul 1
4 citations
Survival and associated predictors for patients with pineoblastoma or pineal parenchymal tumors of intermediate differentiation older than 3 years: Insights from the N...
Panagiotis Kerezoudis, Yagiz Ugur Yolcu, Nadia N Laack, Michael W Ruff, Soumen Khatua, David J Daniels, Terry C Burns, Sani H Kizilbash> ;Neuro-Oncology Advances. 2022 Apr 17
3 citations
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience.
Bryan J Neth, Samantha N Balakrishnan, Ivan D Carabenciov, Joon H Uhm, David J Daniels, Sani H Kizilbash, Michael W Ruff> ;Journal of Neuro-Oncology. 2022 Mar 1
20 citations
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.
Andres Ramos-Fresnedo, Michael W Pullen, Carlos Perez-Vega, Ricardo A Domingo, Oluwaseun O Akinduro, Joao P Almeida, Paola Suarez-Meade, Lina Marenco-Hillembrand, Mark...> ;Journal of Neuro-Oncology. 2022 Mar 1
11 citations
Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial.
Alyx B Porter, Heshan Liu, Sadhna Kohli, Jane L Cerhan, Jeff Sloan, Ryan P McMurray, Jennifer Le-Rademacher, Charles L Loprinzi, John L Villano, Sani H Kizilbash, Mine...> ;JAMA Oncology. 2022 Feb 1
8 citations
In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling.
Sani H. Kizilbash, Shiv K. Gupta, Karen E. Parrish, Janice K. Laramy, Minjee Kim, Gautham Gampa, Brett L. Carlson, Katrina K. Bakken, Ann C. Mladek, Mark A. Schroeder,...> ;Molecular Cancer Therapeutics. 2021 Mar 30
11 citations
Diffuse Gliomas of the Brainstem and Cerebellum in Adults Show Molecular Heterogeneity.
Kathryn L. Eschbacher, Cristiane M. Ida, Derek R. Johnson, Mohammed Ali Alvi, Sarah M. Jenkins, Michael W. Ruff, Panagiotis Kerezoudis, Bryan J. Neth, Romela M Pasion,...> ;The American Journal of Surgical Pathology. 2021 Aug 1
5 citations
Efficacy of 177Lu-Dotatate Therapy in the Treatment of Recurrent Meningioma.
Anza Zahid, Derek R. Johnson, Sani H. Kizilbash> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2021 Jan 14
Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database
Jad Zreik, Panagiotis Kerezoudis, Mohammed Ali Alvi, Yagiz U. Yolcu, Sani H. Kizilbash> ;Frontiers in Oncology. 2021 Jan 1
Join now to see all

Lectures

A phase Ib trial of CB-839 (telaglenastat) in combination with radiation therapy and temozolomide in patients with IDH-mutated diffuse astrocytoma and anaplastic astro...
2019 ASCO Annual Meeting - 6/1/2019